Skip to content
RecallWatchMedical Device Safety
Class IICompletedZ-1490-2026

ESAOTE S.P.A. recalls Esaote Endocavity ultrasonic probe

ESAOTE S.P.A.Sesto Fiorentino, ItalyReported Mar 11, 2026 · 4 months ago
Legal News Analyst ·

Reason for recall

A potential weakness has been identified in the probe body, so that, in a specific production batch, liquid may leak from the terminal part of the casing near the cable.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Esaote Endocavity ultrasonic probe, Model E 3-12, REF120000038
    UDI 0805604453891
    5 affected lots
    241700533C241700529C241700607C241700536C241700613C

What the firm is doing

Esaote issued a Field Safety Notice to its consignees on 3/14/2025 via FedEx. The notice explained the problem with the device, potential risk of use and requested the following: "Actions to be performed by the user " If the operator detects the issue during the inspection, they must NOT use the probe and should contact Esaote's technical support. " Please distribute this Safety Notice to all personnel involved within your organization and to all users of the device. " If the device is no longer in your possession, please provide Esaote with the new owner's details or inform us about the current status of the device. As a precautionary measure, and to complete the root cause analysis while improving our processes and customer service, Esaote will proceed with a voluntary precautionary recall. Our Technical Support Service will soon contact customers who own the affected units to arrange for the replacement of the probe."

DistributionShow details

US: Nationwide distribution in the states of NC and TX.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls